Our previous review described that PPARγ has tumor-promoting activity through the upregulation of β-catenin and c-Myc expression, upregulation of COX-2, upregulation of the expression of vascular endothelial growth factor (VEGF) and VEGF receptors, and upregulation of MMP-1 [8]. The gene discussed is VEGFA; the disease is neoplasm.